Quantum
Home > Boards > US OTC > Cannabis >

MGC Pharmaceuticals (MGCLF)

MGCLF RSS Feed
Add MGCLF Price Alert      Hide Sticky   Hide Intro
Moderator: GonzoinHD, rushmann
Search This Board: 
Last Post: 11/18/2018 8:52:54 PM - Followers: 21 - Board type: Free - Posts Today: 0

MGC Pharmaceutical
Web https://mgcpharma.com.au/

2018 INVESTOR PRESENTATION - A MUST READ
https://www.asx.com.au/asxpdf/20180515/pdf/43v17fngw661gw.pdf


3 DIVISIONS, MGC DERMA, MGC PHARMA, MGC BOTANIC
 
    Our three pioneering divisions allow MGC to be a key player in all significant levels of production in various global locations. It also allows MGC to progress with simultaneous high level research and development, clinical trials around the world and to embrace new emerging verticals in CBD markets.
 
ASX ANNOUNCEMENTS

MAY 2018 INVESTOR PRESENTATION      https://www.asx.com.au/asxpdf/20180515/pdf/43v17fngw661gw.pdf
MGC Gets Malta Deal 4/11/2018.                    https://www.asx.com.au/asxpdf/20180411/pdf/43t3r4swx14w98.pdf
 MGC LAUCHES NUTRACUTICAL LINE                                   https://www.asx.com.au/asxpdf/20180313/pdf/43scvsghl1fc2d.pdf
  MGC OPERATIONAL AND STRATEGY UPDATE                                  https://www.asx.com.au/asxpdf/20180305/pdf/43s586l6nvkppc.pdf
MGC HALF YEAR REPORT                                                     https://www.asx.com.au/asxpdf/20180226/pdf/43rx51n042y5dl.pdf
MGC LAUCHES ON CULT BEAUTY                                      https://www.asx.com.au/asxpdf/20180214/pdf/43rkmpx96lpj7d.pdf
MGC DECEMBER QUARTERLY REPORT                             https://www.asx.com.au/asxpdf/20180131/pdf/43r7dl2c3cv8lc.pdf
MGC INITIAL GMP CERTIFICATION                                   https://www.asx.com.au/asxpdf/20180125/pdf/43r1dqgtgcyhtx.pdf  
MGC LAUCHES PSORIASIS CREAM                                       https://www.asx.com.au/asxpdf/20180104/pdf/43qm6s1tzwb5pw.pdf
PURCHASE ORDER OF $40MIL VC DEAL REC'D                                   https://www.asx.com.au/asxpdf/20171114/pdf/43p6pqsf5jtgcc.pdf
MGC DERMA $40MIL DEAL EXECUTED                             https://www.asx.com.au/asxpdf/20171114/pdf/43p6pqsf5jtgcc.pdf
MGC BOTANICAL DIVISION UPDATE                                 https://www.asx.com.au/asxpdf/20171013/pdf/43n67fw0jy5j5l.pdf
MAJOR EUROPEAN PHARMA DEAL SIGNED                      https://www.asx.com.au/asxpdf/20171003/pdf/43mwyt2nty4zr4.pdf
MULTI MILLION AUSTRALIAN PHARMA DEAL                    https://www.asx.com.au/asxpdf/20171101/pdf/43nvx92qtdfjzm.pdf

Founded in 2014 by experts in the Medical Cannabis field with the intention of capitalising on the emerging global Medical Cannabis industry, founders Nativ Segev and Roby Zomer bring a combination of over 10 years in the Medical Cannabis and the BioTech industry. MGC Pharma was created to become a leading BioPharma company based on Medical Cannabis with operations spanning all aspects of the value chain, from cultivation, manufacturing and distribution of products in a global market.

Today, MGC Pharma has operations spanning Europe and Australia. It has cultivated and harvested crops in its growing facilities in the Czech Republic and Slovenia and is manufacturing active pharmaceutical ingredients (APIs) at its European GMP extraction facility. The Company has also developed a CBD cosmetics range that is available for purchase throughout Europe and online via the Company’s eShop www.mgcderma.com

MGC Botanic

The Botanic Division engages with multiple cultivation sites to meet increasing global demand, alongside research into breeding and genetics with leading institutions and academia. We will continue to harvest the product in Slovenia and Czech Republic, and use the raw material at our production facility, as well as provide the product globally.

Our research & development:

  • We’re excited to embark on a University of Ljubljana botanic research to develop new genetic strains.
    Refining and steadying MGC Pharma’s genetic bank to balance indications and treatment, and to guarantee our ability to produce flawless, high quality products all over the globe.  
    We’ve partnered with Academy of Science, Czech Republic, on numerous strain grows.
MGC Innovation

The Innovation Division is focused on our medical product pipeline and is our largest division. This division focuses on products that emerge from our supply line. These include neutraceuticals, which will be able to provide the additional needs and requirements that our body demands on a daily basis to improve our immune system, detoxify and enhance wellness.

Additionally, this includes our extracts, at various levels of purity, and with the ability to extract various phytocannabinoids and terpenes to the level of Active Pharmaceutical Ingredient.

The Innovation division is  focused on three specific areas of treatment:

  • Neurological disorders, which includes MGC Pharma’s proprietary formulations for Epilepsy
    Oncological care and treatment
    Autoimmune diseases, via taking advantage of the various anti-inflammatory benefits our products have on the body.
MGC Derma is our skincare and anti-aging line for day-to-day use. We are currently working on a new line of dermatological products called DermaPlus, which is already presenting impressive results from clinical studies. MGC Derma is a pioneering CBD cosmetic brand with distribution deals signed in various markets, presently in deliberations to engage in new markets.

MGC Derma produces CBD enhanced cosmetics, DermaPlus dermatological line and private label manufacturing.

Our research & development:

  • Derma Plus product range clinical tests finalized with the three products showing strong improvement in the skin conditions tests.
    Launch of product line in UK, Australia and USA planned for 2018.
 
Our three pioneering divisions allow MGC to be a key player in all significant levels of production in various global locations. It also allows MGC to progress with simultaneous high level research and development, clinical trials around the world and to embrace new emerging verticals in CBD markets.
 
MGC DERMA FEATURED ON CULT BEAUTY     https://www.cultbeauty.co.uk/mgc-derma

  •  
 

MGC Derma

MGC Derma is the brand leading the way in utilising this year’s ‘it’ skin care ingredient: cannabis. Before you get the wrong end of the stick… we’re talking about cannabidiol (CBD) a totally non-psychoactive compound derived from the cannabis plant, which shares part of the ‘fingerprint’ of our genetics, allowing the body to instantly recognise it – and utilise it accordingly. It is MGC Derma’s unique, meticulous extraction and purification process that keeps this ‘fingerprint’ intact; the brand uses only the highest quality cannabidiol in this range of pure yet potent serums, masks, toners and cream. Renowned for its healing, sebum-regulating and moisturising capabilities, CBD is particularly adept at addressing eczema, acne and other problematic skin conditions, as well as minimising signs of ageing, hydrating and nourishing.  

 
 
 

MGC Derma

MGC Derma is the brand leading the way in utilising this year’s ‘it’ skin care ingredient: cannabis. Before you get the wrong end of the stick… we’re talking about cannabidiol (CBD) a totally non-psychoactive compound derived from the cannabis plant, which shares part of the ‘fingerprint’ of our genetics, allowing the body to instantly recognise it – and utilise it accordingly. It is MGC Derma’s unique, meticulous extraction and purification process that keeps this ‘fingerprint’ intact; the brand uses only the highest quality cannabidiol in this range of pure yet potent serums, masks, toners and cream. Renowned for its healing, sebum-regulating and moisturising capabilities, CBD is particularly adept at addressing eczema, acne and other problematic skin conditions, as well as minimising signs of ageing, hydrating and nourishing.  

Quantum
MGCLF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#934   Agreement signed with renowned research universities Love3 11/18/18 08:52:54 PM
#933   So there is a lot not happening with Jmk2454 11/06/18 07:04:31 PM
#932   With the American penny pot stocks heating up GuiNoir 11/03/18 01:13:46 PM
#931   Market Announcement 1 November 2018 Love3 10/31/18 07:22:42 PM
#930   https://hotcopper.com.au/documentdownload?id=uOMxKKzFkiWRTLKhOROKAxjvTDYD4wi7wBa Love3 10/29/18 11:42:57 PM
#929   Fantastic article!! Very detailed regarding our MGC. There rushmann 10/29/18 05:26:37 PM
#928   https://www.edisoninvestmentresearch.com/researchreports/AU000000MXC6MGC%20Pharm Cooklamo 10/29/18 02:48:14 PM
#927   https://stockhead.com.au/health/mgc-is-undervalued-as-pharma-and-cannabis-ingred londonohoyos 10/26/18 06:03:45 AM
#926   https://www.fool.com.au/2018/10/26/these-small-cap-asx-shares-are-ending-the-wee londonohoyos 10/26/18 05:58:55 AM
#925   MGC Pharmaceuticals Ltd (ASX: MXC or “the Company”) londonohoyos 10/26/18 05:52:45 AM
#924   Looks like a couple people need beer money GonzoinHD 10/19/18 10:36:56 AM
#923   Thank you for the update. October 31st is GonzoinHD 10/19/18 09:41:43 AM
#922   An announcement from MGC tonight said the date Jmk2454 10/18/18 10:08:27 PM
#921   Cannaglobalco.com GonzoinHD 10/18/18 10:39:21 AM
#920   What's the website? rushmann 10/18/18 10:07:29 AM
#919   I’m suppose we’ll all be checking it multiple GonzoinHD 10/17/18 05:31:35 PM
#918   Hmmmm......... I see Cannaglobal has finally got what GonzoinHD 10/17/18 05:30:31 PM
#917   624,223 volume today is much higher than most GuiNoir 10/16/18 07:33:44 PM
#916   Trading halt may be due to the 1 rushmann 10/16/18 05:08:40 PM
#915   I agree with you that Australia is no GonzoinHD 10/16/18 02:49:20 PM
#914   Still think the really big news is getting GuiNoir 10/16/18 02:19:02 PM
#913   Couple the news of the UK legalizing MM GonzoinHD 10/16/18 01:09:38 PM
#912   Ok, for those who haven’t figured it out GonzoinHD 10/16/18 12:52:49 PM
#911   The announcement is a trading halt. I’m sure GonzoinHD 10/16/18 01:12:54 AM
#910   Market Release Oct 16, 2018 Love3 10/16/18 12:44:07 AM
#909   New announcement coming any moment. Trading paused on GonzoinHD 10/16/18 12:37:20 AM
#908   Exciting to watch the action in Australia tonight. GonzoinHD 10/15/18 11:40:06 PM
#907   Typical pink sheet move. US investors know very rushmann 10/15/18 02:08:25 PM
#906   GonzoinHD...congrats!!! PM your cell#, if you want, and rushmann 10/15/18 02:05:47 PM
#905   MXC gets approval for its epilepsy drug in GuiNoir 10/15/18 11:59:31 AM
#904   You have a very good handle on things. rushmann 10/12/18 04:28:24 PM
#903   Sure, I’ll look into submitting a request to GonzoinHD 10/12/18 03:30:12 PM
#902   Hey Boston, are you still following LDS*? BullMarket34 10/12/18 01:28:10 PM
#901   MGC is now in the fast lane. The rushmann 10/12/18 01:01:55 PM
#900   Lock up your shares folks (limit sell order BostonErin 10/12/18 09:01:19 AM
#899   Time for you to be a moderator... rushmann 10/11/18 06:17:53 PM
#898   3000 patients at 1million per 100 patients is Love3 10/11/18 12:29:43 PM
#897   Why isn’t my E*TRADE reflecting the gains they Love3 10/11/18 12:26:14 PM
#896   Well said and you brought up very good Jmk2454 10/11/18 06:25:50 AM
#895   I don’t have an answer to that question. GonzoinHD 10/11/18 12:11:13 AM
#894   Great question I would like to know as well! Cooklamo 10/10/18 11:25:33 PM
#893   It’s doing great on the ASX tonight. But Jmk2454 10/10/18 10:40:02 PM
#892   Looking good on the ASX right now. Last GonzoinHD 10/10/18 09:41:01 PM
#891   And so the Cannepil shoe finally drops!! One rushmann 10/10/18 09:37:28 PM
#890   CannEpilTM available for Australian supply under Authorised Prescriber Scheme Love3 10/10/18 08:15:37 PM
#889   It seems that those in Australia trudging through GonzoinHD 10/09/18 04:08:36 PM
#888   What is the news coming out? Anyone know? jk1283 10/09/18 05:17:18 AM
#887   CannEpil! GonzoinHD 10/08/18 07:07:57 PM
#886   Yeah, very interesting. The MGC plot thickens more rushmann 10/08/18 01:52:59 PM
#885   Anyone else find it interesting that of the GonzoinHD 10/07/18 12:16:13 PM
PostSubject